Literature DB >> 16621820

Mutation of waaC, encoding heptosyltransferase I in Campylobacter jejuni 81-176, affects the structure of both lipooligosaccharide and capsular carbohydrate.

Margaret I Kanipes1, Erzsebet Papp-Szabo, Patricia Guerry, Mario A Monteiro.   

Abstract

Campylobacter jejuni 81-176 lipooligosaccharide (LOS) is composed of two covalently linked domains: lipid A, a hydrophobic anchor, and a nonrepeating core oligosaccharide, consisting of an inner and outer core region. We report the isolation and characterization of the deepest rough C. jejuni 81-176 mutant by insertional mutagenesis into the waaC gene, encoding heptosyltransferase I that catalyzes the transfer of the first L-glycero-D-manno-heptose residue to 3-deoxy-D-manno-octulosonic residue (Kdo)-lipid A. Tricine gel electrophoresis, followed by silver staining, showed that site-specific mutation in the waaC gene resulted in the expression of a severely truncated LOS compared to wild-type strain 81-176. Gas-liquid chromatography-mass spectrometry and nuclear magnetic resonance spectroscopy showed that the waaC LOS species lacked all sugars distal to Kdo-lipid A. Parallel structural studies of the capsular polysaccharides of the wild-type strain 81-176 and waaC mutant revealed loss of the 3-O-methyl group in the waaC mutant. Complementation of the C. jejuni mutant by insertion of the wild-type C. jejuni waaC gene into a chromosomal locus resulted in LOS and capsular structures identical to those expressed in the parent strain. We also report here the presence of O-methyl phosphoramidate in wild-type strain 81-176 capsular polysaccharide.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16621820      PMCID: PMC1447440          DOI: 10.1128/JB.188.9.3273-3279.2006

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  30 in total

1.  A phase-variable capsule is involved in virulence of Campylobacter jejuni 81-176.

Authors:  D J Bacon; C M Szymanski; D H Burr; R P Silver; R A Alm; P Guerry
Journal:  Mol Microbiol       Date:  2001-05       Impact factor: 3.501

2.  Phase variation of a beta-1,3 galactosyltransferase involved in generation of the ganglioside GM1-like lipo-oligosaccharide of Campylobacter jejuni.

Authors:  D Linton; M Gilbert; P G Hitchen; A Dell; H R Morris; W W Wakarchuk; N A Gregson; B W Wren
Journal:  Mol Microbiol       Date:  2000-08       Impact factor: 3.501

3.  Characterization of the Campylobacter jejuni heptosyltransferase II gene, waaF, provides genetic evidence that extracellular polysaccharide is lipid A core independent.

Authors:  Neil J Oldfield; Anthony P Moran; Lorna A Millar; Martina M Prendergast; Julian M Ketley
Journal:  J Bacteriol       Date:  2002-04       Impact factor: 3.490

4.  The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide.

Authors:  Michel Gilbert; Marie-France Karwaski; Stéphane Bernatchez; N Martin Young; Eduardo Taboada; Joseph Michniewicz; Anna-Maria Cunningham; Warren W Wakarchuk
Journal:  J Biol Chem       Date:  2001-10-31       Impact factor: 5.157

5.  Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro.

Authors:  Patricia Guerry; Christine M Szymanski; Martina M Prendergast; Thomas E Hickey; Cheryl P Ewing; Dawn L Pattarini; Anthony P Moran
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

6.  Changes in flagellin glycosylation affect Campylobacter autoagglutination and virulence.

Authors:  Patricia Guerry; Cheryl P Ewing; Michael Schirm; Maria Lorenzo; John Kelly; Dawn Pattarini; Gary Majam; Pierre Thibault; Susan Logan
Journal:  Mol Microbiol       Date:  2006-04       Impact factor: 3.501

7.  Involvement of a plasmid in virulence of Campylobacter jejuni 81-176.

Authors:  D J Bacon; R A Alm; D H Burr; L Hu; D J Kopecko; C P Ewing; T J Trust; P Guerry
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

8.  Cell-surface alpha-glucan in Campylobacter jejuni 81-176.

Authors:  Erzsébet Papp-Szabó; Margaret I Kanipes; Patricia Guerry; Mario A Monteiro
Journal:  Carbohydr Res       Date:  2005-09-26       Impact factor: 2.104

9.  Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuni.

Authors:  P Guerry; C P Ewing; T E Hickey; M M Prendergast; A P Moran
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

10.  The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.

Authors:  Peggy C R Godschalk; Astrid P Heikema; Michel Gilbert; Tomoko Komagamine; C Wim Ang; Jobine Glerum; Denis Brochu; Jianjun Li; Nobuhiro Yuki; Bart C Jacobs; Alex van Belkum; Hubert P Endtz
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

View more
  22 in total

1.  Creation of a large deletion mutant of Campylobacter jejuni reveals that the lipooligosaccharide gene cluster is not required for viability.

Authors:  Gemma L Marsden; Jianjun Li; Paul H Everest; Andrew J Lawson; Julian M Ketley
Journal:  J Bacteriol       Date:  2009-01-30       Impact factor: 3.490

2.  Characterization of two Campylobacter jejuni strains for use in volunteer experimental-infection studies.

Authors:  Frédéric Poly; Timothy D Read; Yu-Han Chen; Mario A Monteiro; Oralak Serichantalergs; Piyarat Pootong; Ladaporn Bodhidatta; Carl J Mason; David Rockabrand; Shahida Baqar; Chad K Porter; David Tribble; Michael Darsley; Patricia Guerry
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

3.  Phenotypic and genotypic characterizations of Campylobacter jejuni isolated from the broiler meat production process.

Authors:  Eglė Kudirkienė; Marianne Thorup Cohn; Richard A Stabler; Philippa C R Strong; Loreta Sernienė; Brendan W Wren; Eva Møller Nielsen; Mindaugas Malakauskas; Lone Brøndsted
Journal:  Curr Microbiol       Date:  2012-06-27       Impact factor: 2.188

4.  Characterization of the dTDP-Fuc3N and dTDP-Qui3N biosynthetic pathways in Campylobacter jejuni 81116.

Authors:  Zack Z Li; Alexander S Riegert; Marie-France Goneau; Anna M Cunningham; Evgeny Vinogradov; Jianjun Li; Ian C Schoenhofen; James B Thoden; Hazel M Holden; Michel Gilbert
Journal:  Glycobiology       Date:  2017-04-01       Impact factor: 4.313

Review 5.  The sweet tooth of bacteria: common themes in bacterial glycoconjugates.

Authors:  Hanne L P Tytgat; Sarah Lebeer
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

6.  Cj1136 is required for lipooligosaccharide biosynthesis, hyperinvasion, and chick colonization by Campylobacter jejuni.

Authors:  Muhammad Afzal Javed; Shaun A Cawthraw; Abiyad Baig; Jianjun Li; Alan McNally; Neil J Oldfield; Diane G Newell; Georgina Manning
Journal:  Infect Immun       Date:  2012-04-16       Impact factor: 3.441

7.  Phase-Variable Changes in the Position of O-Methyl Phosphoramidate Modifications on the Polysaccharide Capsule of Campylobacter jejuni Modulate Serum Resistance.

Authors:  Brittany Pequegnat; Renee M Laird; Cheryl P Ewing; Christina L Hill; Eman Omari; Frederic Poly; Mario A Monteiro; Patricia Guerry
Journal:  J Bacteriol       Date:  2017-06-27       Impact factor: 3.490

8.  Synthesis, kinetics and inhibition of Escherichia coli Heptosyltransferase I by monosaccharide analogues of Lipid A.

Authors:  Noreen K Nkosana; Daniel J Czyzyk; Zarek S Siegel; Joy M Cote; Erika A Taylor
Journal:  Bioorg Med Chem Lett       Date:  2018-02-02       Impact factor: 2.823

9.  Genetic analysis of lipooligosaccharide core biosynthesis in Campylobacter jejuni 81-176.

Authors:  Margaret I Kanipes; Xuan Tan; Aurel Akelaitis; Jiajun Li; David Rockabrand; Patricia Guerry; Mario A Monteiro
Journal:  J Bacteriol       Date:  2007-12-21       Impact factor: 3.490

10.  Capsule polysaccharide conjugate vaccine against diarrheal disease caused by Campylobacter jejuni.

Authors:  Mario A Monteiro; Shahida Baqar; Eric R Hall; Yu-Han Chen; Chad K Porter; David E Bentzel; Lisa Applebee; Patricia Guerry
Journal:  Infect Immun       Date:  2008-12-29       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.